IFNB1 and cancer: APCs provide CTLs with three required activation signals, namely (1) the cancer antigen epitope mounted on MHCI, (2) co-stimulatory molecules such as CD80/86 and CD40, and (3) pro-inflammatory cytokines such as IL-12, IFNβ and TNFα (Locy et al., 2018).